首页> 外文期刊>Cell death & disease. >Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma
【24h】

Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma

机译:肿瘤抑制物PDCD4调节miR-184介导的直接抑制C-MYC和BCL2阻断鼻咽癌中细胞的生长和存活

获取原文
           

摘要

Programmed cell death 4 (PDCD4), a novel tumor suppressor, inhibits cell proliferation, migration and invasion as well as promotes cell apoptosis in tumors. However, the molecular mechanism of its tumor-suppressive function remains largely unknown in tumors including nasopharyngeal carcinoma (NPC). In this study, downregulated PDCD4 expression was significantly associated with the status of NPC progression and poor prognosis. PDCD4 markedly suppressed the ability of cell proliferation and cell survival by modulating C-MYC-controlled cell cycle and BCL-2-mediated mitochondrion apoptosis resistance signals, and oncogenic transcription factor C-JUN in NPC. Furthermore, miR-184, a tumor-suppressive miRNA modulated by PDCD4 directly targeting BCL2 and C-MYC, participated in PDCD4-mediated suppression of cell proliferation and survival in NPC. Further, we found that PDCD4 decreased the binding of C-Jun to the AP-1 element on the miR-184 promoter regions by PI3K/AKT/JNK/C-Jun pathway and stimulated miR-184 expression. In clinical fresh specimens, reduced PDCD4 mRNA level was positively correlated with miR-184 expression in NPC. Our studies are the first to demonstrate that PDCD4 as tumor suppressor regulated miR-184-mediated direct targeting of BCL2 and C-MYC via PI3K/AKT and JNK/C-Jun pathway attenuating cell proliferation and survival in NPC.
机译:程序性细胞死亡4(PDCD4)是一种新型的肿瘤抑制因子,可抑制细胞增殖,迁移和侵袭,并促进肿瘤细胞凋亡。然而,在包括鼻咽癌(NPC)在内的肿瘤中,其抑癌功能的分子机制仍是未知之数。在这项研究中,PDCD4表达下调与NPC进展和不良预后显着相关。 PDCD4通过调节C-MYC控制的细胞周期和BCL-2介导的线粒体凋亡抗性信号以及致癌转录因子C-JUN来显着抑制细胞增殖和细胞存活的能力。此外,miR-184是由直接靶向BCL2和C-MYC的PDCD4调节的肿瘤抑制性miRNA,参与了PDCD4介导的NPC细胞增殖和存活的抑制。此外,我们发现PDCD4通过PI3K / AKT / JNK / C-Jun途径降低了C-Jun与miR-184启动子区域上AP-1元素的结合,并刺激了miR-184的表达。在临床新鲜标本中,PDCD4 mRNA水平降低与NPC中miR-184的表达呈正相关。我们的研究首次证明PDCD4作为肿瘤抑制因子,可通过PI3K / AKT和JNK / C-Jun途径调节miR-184介导的BCL2和C-MYC的直接靶向,从而减弱NPC的细胞增殖和存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号